Prostaglandin E2 Signaling: Alternative Target for Glioblastoma?

被引：62
|
作者：
Jiang, Jianxiong [1 ]
Qiu, Jiange [1 ,2 ,3 ]
Li, Qianqian [1 ]
Shi, Zhi [2 ,3 ]
机构：
[1] Univ Cincinnati, Acad Hlth Ctr, James L Winkle Coll Pharm, Div Pharmaceut Sci, Cincinnati, OH 45267 USA
[2] Jinan Univ, Coll Life Sci & Technol, Natl Engn Res Ctr Genet Med, Guangdong Prov Key Lab Bioengn Med,Dept Cell Biol, Guangzhou 510632, Guangdong, Peoples R China
[3] Jinan Univ, Coll Life Sci & Technol, Guangdong Prov Key Lab Bioengn Med, Natl Engn Res Ctr Genet Med,Inst Biomed, Guangzhou 510632, Guangdong, Peoples R China
来源：
TRENDS IN CANCER | 2017年 / 3卷 / 02期
基金：
美国国家卫生研究院; 中国国家自然科学基金;
关键词：
GLIOMA-CELL GROWTH; RECEPTOR EP2; E SYNTHASE-1; INFLAMMATION; MICROGLIA; SURVIVAL; CANCER;
D O I：
10.1016/j.trecan.2016.12.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Elevated cyclooxygenase-2 (COX-2) and the associated inflammation within the brain contribute to glioblastoma development. However, medical use of COX inhibitors in glioblastoma treatment has been limited due to their well-documented vascular toxicity and inconsistent outcomes from recent human studies. Prostaglandin E2 (PGE2) has emerged as a principal mediator for COX-2 cascade-driven gliomagenesis. Are PGE(2) terminal synthases and receptors feasible therapeutic targets for glioblastoma?
引用
收藏
页码：75 / 78
页数：4
相关论文
共 50 条
  • [1] Prostaglandin E2 synthase inhibition as a therapeutic target
    Iyer, Jitesh P.
    Srivastava, Punit K.
    Dev, Rishabh
    Dastidar, Sunanda G.
    Ray, Abhijit
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (07) : 849 - 865
  • [2] Harnessing prostaglandin E2 signaling to ameliorate autoimmunity
    Burkett, Juliann B.
    Doran, Amanda C.
    Gannon, Maureen
    TRENDS IN IMMUNOLOGY, 2023, 44 (03) : 162 - 171
  • [3] Prostaglandin E2 in neuroblastoma: Targeting synthesis or signaling?
    Hou, Ruida
    Yu, Ying
    Jiang, Jianxiong
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 156
  • [4] Prostaglandin E2 Signaling as a Target of Anti-Cardiac Fibrosis in Heart Failure Treatment
    Harada, Mutsuo
    Takeda, Norifumi
    Toko, Haruhiro
    INTERNATIONAL HEART JOURNAL, 2017, 58 (01) : 3 - 4
  • [5] Revisiting prostaglandin E2: A promising therapeutic target for osteoarthritis
    Yang, Dinglong
    Xu, Ke
    Xu, Xin
    Xu, Peng
    CLINICAL IMMUNOLOGY, 2024, 260
  • [6] Prostanoid signaling: Dual role for prostaglandin E2 in neurotoxicity
    Milatovic, Dejan
    Montine, Thomas J.
    Aschner, Michael
    NEUROTOXICOLOGY, 2011, 32 (03) : 312 - 319
  • [7] Regulation of purinergic signaling by prostaglandin E2 in murine macrophages
    Ito, Masaaki
    Matsuoka, Isao
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 107 (04) : 443 - 450
  • [8] Therapeutic targets in prostaglandin E2 signaling for neurologic disease
    Cimino, P. J.
    Keene, C. Dirk
    Breyer, Richard M.
    Montine, Kathleen S.
    Montine, Thomas J.
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (19) : 1863 - 1869
  • [9] Prostaglandin E2 signaling in pathophysiology of endometriosis in human.
    Arosh, Joe
    Lee, JeHoon
    Rodriguez, Royce
    Starzinski-Powitz, Anna
    Bann, Sakhila
    BIOLOGY OF REPRODUCTION, 2007, : 157 - 157
  • [10] Microsomal prostaglandin E2 synthase:: A safer target than cyclooxygenases?
    Timmers, Leo
    Pasterkamp, Gerard
    de Kleijn, Dominique P. V.
    MOLECULAR INTERVENTIONS, 2007, 7 (04) : 195 - 198
12345